Japanese pharma giant Astellas Pharma Inc. and The University of Texas MD Anderson Cancer Center has signed an option ag...
Singapore: Merck Millipore, the Life Science division of Merck, has appointed Dr Udit Batra as its new President and CEO...
Singapore: US Pharmacopeial Convention (USP), a nonprofit global health organization that creates and promotes quality s...
Singapore: Adagene, China based antibody discovery and development company, has raised USD28 million Series B financing ...
‎Singapore: Merck Serono, the biopharmaceutical division of Merck, has signed a global licensing, co-development, ...
Singapore: Pneumonia remains the single biggest killer of children under the age of five globally, claiming the lives of...
Singapore: Australia-based Patrys, a clinical stage biotechnology company, has been granted orphan drug designation by t...
Singapore: US-Australian drug discovery company, Novogen's drug candidate, Anisina, has progressed successfully in pre-c...
Over the past decade the world's centre of economic gravity has shifted from US and Europe to Asia at a speed and scale ...
Singapore: A research team led by scientists from National University of Singapore (NUS) has identified several potent i...
Singapore: China biotech firm, Innovent Biologics, has raised $100 million in Series C financing led by Legend Capital, ...
Singapore: Scientific consensus in the Network Verification Challenge, conducted in Spain from 15-18 June 2015, has exhi...
Dr Alex Matter, CEO, Experimental Therapeutics Center, A*Star, Singapore, is among the pioneers of the world's first tar...
Singapore: Cancer Council NSW, Australia's non-government cancer research funder, has granted almost $7 million to resea...
Singapore: US-Australian drug discovery company, Novogen, in conjunction with Australian paediatric cancer researchers, ...
Singapore: The World Health Organization (WHO) is urging governments to act against the five hepatitis viruses that can...
Singapore: Australian drug discovery company, Novogen, has developed anti-tropomyosin drug candidate, Anisina, which has...
Singapore: Australia-based Starpharma Holdings has achieved improved tumor-inhibiting efficacy and reduced overall toxic...
